SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2744Nereus now claims effectiveness against MM resistant to Velcade: >>Br J Ctuck-10/20/2006
2743Millennium renews hunt after losing AnorMed to Genzyme By Stephen Heuser, Globe Icebrg-10/18/2006
2742Millennium Issues Statement Regarding AnorMED Inc. Tuesday October 17, 3:01 am EIcebrg-10/17/2006
2741Millennium reviewing Genzyme bid for AnorMed, decision expected by Monday [AnorIcebrg-10/13/2006
2740I'm not seeing a bump. Millenium has three days (business days?) to respondtuck-10/12/2006
2739Now the big Q is whether MLNM is smart enough to bow out; or, are they pigheadedIan@SI-10/12/2006
2738<i>A little more detail (I always enjoy contested bids, & we don'tnigel bates-10/11/2006
2737Presuming that the board responds tomorrow, perhaps MLNM will see a bump on ThurIan@SI-10/11/2006
2736Perhaps the market thinks MLNM will do something stupid and top GENZ?tom pope-10/10/2006
2735>>9:50AM Anormed: Genzyme announces proposal to increase its offer to acqutuck-10/10/2006
2734[Proteasome subunits and sensitivity of leukemia cells to bortezomib] >>Ltuck-10/8/2006
2733[Enzastaurin and Velcade versus multiple myeloma] >>Blood. 2006 Oct 5; [Etuck-10/8/2006
2732I would agree she inherited a greater mess and has been diligently trying to getmopgcw-10/7/2006
2731MLN120B, a Novel I{kappa}B Kinase {beta} Inhibitor, Blocks Multiple Myeloma CellIcebrg-10/7/2006
2730>>I just think they are grasping in general with little focus or intent.&gIcebrg-10/7/2006
2729<i> is slightly under water, too. </i> sorry to hear. I bought in mopgcw-10/7/2006
2728[MLN-4760 for albuminuria and glomerular injury] MLN-4760 was under developmenttuck-10/7/2006
2727fwiw, i am out. it has been a huge disappoint for me, been in and out since mopgcw-10/6/2006
2726Journal of Clinical Oncology Publishes Final Study Results of VELCADE(R) (BortezIan@SI-10/6/2006
2725Merrill Genzyme at Risk of Overbidding For Anormed We believe GENZ is at risk tom pope-10/6/2006
2724As usual you have a very good grip on this, and I can see you've gone back skeokalani'nui-10/3/2006
2723Mozobil is the same CXCR4 inhibitor that was used in AIDS trials, right, except tuck-10/3/2006
2722[CXCR4 inhibition (Mozobil) and breast cancer] "CXCL-12/Stromal Cell–Derivtuck-9/30/2006
2721CXCR4 versus multiple myeloma This ia full text freebie, BTW: haematologica.ortuck-9/30/2006
2720Mechanism of Action/Scientific Background from CIBC report Mobilization allows idos-9/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News